Vitrolife AB (publ)
VTRLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,031 | $19,039 | $24,462 | $28,090 |
| - Cash | $118 | $921 | $1,054 | $1,135 |
| + Debt | $213 | $1,993 | $1,951 | $2,089 |
| Enterprise Value | $2,126 | $20,111 | $25,359 | $29,044 |
| Revenue | $88 | $871 | $842 | $959 |
| % Growth | -89.9% | 3.4% | -12.2% | – |
| Gross Profit | $45 | $505 | $483 | $586 |
| % Margin | 51% | 58% | 57.4% | 61.1% |
| EBITDA | $27 | $137 | $150 | $271 |
| % Margin | 30.5% | 15.7% | 17.8% | 28.3% |
| Net Income | $11 | $100 | $100 | $139 |
| % Margin | 12.2% | 11.5% | 11.9% | 14.5% |
| EPS Diluted | 0.079 | 0.74 | 0.74 | 1.02 |
| % Growth | -89.3% | 0% | -27.5% | – |
| Operating Cash Flow | $26 | $151 | $69 | $268 |
| Capital Expenditures | -$6 | $0 | $0 | $0 |
| Free Cash Flow | $20 | $151 | $69 | $268 |